Novogene Balance Sheet Health
Financial Health criteria checks 6/6
Novogene has a total shareholder equity of CN¥2.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.5B and CN¥1.0B respectively. Novogene's EBIT is CN¥182.5M making its interest coverage ratio -6.2. It has cash and short-term investments of CN¥1.2B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -6.2x |
| Cash | CN¥1.25b |
| Equity | CN¥2.45b |
| Total liabilities | CN¥1.03b |
| Total assets | CN¥3.48b |
Recent financial health updates
No updates
Recent updates
Earnings Working Against Novogene Co., Ltd.'s (SHSE:688315) Share Price
Sep 27
Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%
Jun 07Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook
Apr 17Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)
Mar 25Financial Position Analysis
Short Term Liabilities: 688315's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥1.0B).
Long Term Liabilities: 688315's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥21.2M).
Debt to Equity History and Analysis
Debt Level: 688315 is debt free.
Reducing Debt: 688315 has no debt compared to 5 years ago when its debt to equity ratio was 16.8%.
Debt Coverage: 688315 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688315 has no debt, therefore coverage of interest payments is not a concern.